Frequency of CYP2D6*10 and *14 alleles and their influence on the metabolic activity of CYP2D6 in a healthy Chinese population

Clinical Pharmacology and Therapeutics

Volumn 81, Issue 1, 2007, Pages 95-98

  Cai, W M ^a   Chen, B ^a   Zhang, W X ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; DEXTROMETHORPHAN;

ADULT; ARTICLE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; MALE; METABOLIC ACTIVATION; MOLECULAR PROBE; NORMAL HUMAN; PRIORITY JOURNAL; ASIAN; CHINA; GENETICS; GENOTYPE; METABOLISM; PHENOTYPE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CYTOCHROME P-450 CYP2D6; DEXTROMETHORPHAN; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; PHENOTYPE;

EID: 33846019978     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/sj.clpt.6100015     Document Type: Article

References (20)

1. Cai, W.M., Chen, B., Liu, Y.X. & Chu, X. Dextromethorphan metabolic phenotyping in a Chinese population. Acta Pharmacol. Sin. 18, 441-444 (1997).
2. Tateishi, T., Chida, M., Ariyoshi, N., Mizorogi, Y., Kamataki, T. & Kobayashi, S. Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population. Clin. Pharmacol. Ther. 65, 570-575 (1999).
3. Kimiskidis, V.K. et al. Frequency distribution of dextromethorphan O-demethylation in a Greek population. Int. J. Clin. Pharmacol. Ther. 43, 150-153 (2005).
4. Tamminga, W.J. et al. CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differences. Eur. J. Clin. Pharmacol. 55, 177-184 (1999).
5. Sachse, C., Brockmoller, J., Bauer, S. & Roots, I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am. J. Hum. Genet. 60, 284-295 (1997).
6. Griese, E.U. et al. Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics 8, 15-26 (1998).
7. Ingelman-Sundberg, M., Daly, A.K. & Nebert, D.W. Homepage of the human cytochrome P450 (CYP) allele nomenclature committee, http://www.imm.ki.se/CYPalleles.
8. Kubota, T., Yamaura, Y., Ohkawa, N., Hara, H. & Chiba, K. Frequencies of CYP2D6 variant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes. Br. J. Clin. Pharmacol. 50, 31-34 (2000).
9. Ji, L., Pan, S., Marti-Jaun, J., Hanseler, E., Rentsch, K. & Hersberger, M. Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14B allele in mainland Chinese. Clin. Chem. 48, 983-988 (2002).
10. Ramamoorthy, Y., Tyndale, R.F. & Sellers, E.M. Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates. Pharmacogenetics 11, 477-487 (2001).
11. Garcia-Barcelo, M. et al. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population. Clin. Chem. 46, 1873 (2000).
12. Ishida, S. et al. Determination of CYP2D6 gene alleles by the CYP450 probe array using the Affymetrix GeneChip system: comparison with sequencing results. Drug. Metab. Pharmacokinet. 17, 157-160 (2002).
13. Wang, S.L., Lai, M.D. & Huang, J.D. G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese. Drug Metab. Dispos. 27, 385-388 (1999).
14. Garcia-Barcelo, M. et al. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population. Clin. Chem. 46, 18-23 (2000).
15. Lee, E.J. & Jeyaseelan, K. Frequency of human CYP2D6 mutant alleles in a normal Chinese population. Br. J. Clin. Pharmacol. 37, 605-607 (1994).
16. Shiraishi, T. et al. Effects of G169R and P34S substitutions produced by mutations of CYP2D6*14 on the functional properties of CYP2D6 expressed in V79 cells. Drug Metab. Dispos. 30, 1201-1205 (2002).
17. Kitada, M. Genetic polymorphism of cytochrome P450 enzymes in Asian populations: focus on CYP2D6. Int. J. Clin. Pharmacol. Res. 23, 31-35 (2003).
18. Rogan, P.K., Svojanovsky, S. & Leeder, J.S. Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations. Pharmacogenetics 13, 207-218 (2003).
19. Bu, Y., Zhang, X.D., Ma, T. & Zhou, G.H. An efficient approach to human CYP2D6*10 allele-specific typing by polymerase chain reaction with five primers in a single tube. Chin. J. Anal. Chem. 33, 155-160 (2005).
20. Cai, W.M., Chen, B. & Chu, X. High performance liquid chromatographic determination of dextromethorphan and its metabolite in human urine. Yao Xue Xue Bao 32, 861-864 (1997).